Market revenue in 2023 | USD 126.0 million |
Market revenue in 2030 | USD 223.7 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Nylon |
Fastest growing segment | Polyurethane |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nylon, Polyurethane, Other Material Type |
Key market players worldwide | Medtronic PLC, Terumo Corp, Cardinal Health Inc, Boston Scientific Corp, Traeger Inc, BIOTRONIK, Surmodics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pta balloon catheter market will help companies and investors design strategic landscapes.
Nylon was the largest segment with a revenue share of 49.6% in 2023. Horizon Databook has segmented the Japan pta balloon catheter market based on nylon, polyurethane, other material type covering the revenue growth of each sub-segment from 2018 to 2030.
Favorable healthcare policies in Japan are among major factors expected to drive the market over the forecast period. The Japanese healthcare system ensures that every citizen is entitled to care across the country at all times. Furthermore, due to such favorable policies, authorities are working toward upgrading equipment in every part of the country to deliver advanced care.
Some of the upgradations are reforms in social security system to help patients receive better care and increase in specialized hospitals. Such factors may encourage many new and key players to enter the market in the country. For instance, Kossel Medical Selepass received the approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) to sell of its PTCA Balloon Dilation Catheter, Selepass, and NC PTCA Balloon Dilation Catheter in Japan.
Furthermore, in March 2022, Endovastec announced that its proprietary Hyperflex balloon catheter received registration approval from the PMDA, which is the company's first product approved for sale in Japan. Hyperflex got its CE marking in 2016 and is already on the international market in South America and Asia.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan pta balloon catheter market , including forecasts for subscribers. This country databook contains high-level insights into Japan pta balloon catheter market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account